EcoDrugPlus

Somatostatin Receptor 2

Ensembl ID : ENSPKIG00000023422
Gene Symbol: SSTR2
4 Cross references
192 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSPKIG00000003399
Gene Symbol: SSTR5
1 Cross references
188 Possible Orthologues:

Somatostatin Receptor Type 2-Like

Ensembl ID : ENSPKIG00000025156
Gene Symbol: LOC111860599
2 Cross references
192 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSPKIG00000011535
Gene Symbol: SPHK2
3 Cross references
202 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSPKIG00000002010
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSPKIG00000020872
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSPKIG00000001260
Gene Symbol: LOC111836781
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSPKIG00000019552
Gene Symbol: SRD5A2
4 Cross references
260 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSPKIG00000007623
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSPKIG00000006276
Gene Symbol: SNCA
3 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSPKIG00000009547
Gene Symbol: TACR1
3 Cross references
202 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSPKIG00000020545
Gene Symbol: TACR1
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).